Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hom

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
Nature|July 24, 2024
A temperate super-Jupiter imaged with JWST in the mid-infraredE C Matthews, A L Carter, P Pathak, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridyloxypropanolamine agonists of the beta 3 adrenergic receptor with improved pharmacokinetic propertiesA E Weber, H O Ok, R F Alvaro, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
Nature|July 24, 2024
A temperate super-Jupiter imaged with JWST in the mid-infraredE C Matthews, A L Carter, P Pathak, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridyloxypropanolamine agonists of the beta 3 adrenergic receptor with improved pharmacokinetic propertiesA E Weber, H O Ok, R F Alvaro, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Pageof 7